Literature DB >> 15110447

Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy.

Masashi Koto1, Tadaaki Miyamoto, Naoyoshi Yamamoto, Hideki Nishimura, Shogo Yamada, Hirohiko Tsujii.   

Abstract

BACKGROUND AND
PURPOSE: For a proper evaluation of the relationship between carbon ion beam dose escalation and local control in the 81 patients with 82 lesions of stage I non-small cell lung cancer, we have identified the incidence of in-field recurrence by collating the dose distribution with the CT images. PATIENTS AND METHODS: Eighteen fractions over 6 weeks for 47 patients (48 lesions) and nine fractions over 3 weeks for 34 patients were applied in the carbon dose escalation method from 59.4 to 95.4 gray equivalents (GyE) by a 10% increment and from 68.4 to 79.2GyE by a 5% increment, respectively. The radiation target consisted of primary tumor. Image analysis of the patients with local recurrence was systematically performed after the treatment by focusing attention on the enhanced thin slice CT images of the primary lesion. By superimposing the dose distribution on the planning CT image and marking the anatomically identified loci of recurrence, it was possible to establish the relationship between the dose distribution and the incipient loci of recurrence and to classify the recurrence patterns from the differences in the recurrence loci.
RESULTS: Local recurrence was found in 19 (23.2%) out of a total of 82 lesions. It is possible to distinguish between three recurrence patterns: Pattern 1 representing marginal recurrence and patterns 2a and 2b, which are both instances of in-field recurrence. In pattern 1, four recurrences take place from a region on the upper tumor margin. In pattern 2a, 13 recurrences take place from the center of the tumor. In pattern 2b, two recurrences take place from the near-center of the tumor.
CONCLUSIONS: For the 15 in-field recurrence lesions (patterns 2a and 2b) after excluding the four marginal recurrence lesions (patterns 1), we have established that the local control shows dose-dependence. Based on this, we have determined the optimal therapeutic dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110447     DOI: 10.1016/j.radonc.2004.02.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

Review 1.  Review of clinical experience with ion beam radiotherapy.

Authors:  A D Jensen; M W Münter; J Debus
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 2.  Current status and future prospects of multi-dimensional image-guided particle therapy.

Authors:  Shinichiro Mori; Silvan Zenklusen; Antje-Christin Knopf
Journal:  Radiol Phys Technol       Date:  2013-02-19

3.  Heavy ion irradiation increases apoptosis and STAT-3 expression, led to the cells arrested at G2/M phase in human hepatoma SMMC-7721 cells.

Authors:  Jianxun Ma; Lanping Ye; Mingxu Da; Xiaopeng Wang
Journal:  Mol Cell Biochem       Date:  2009-03-13       Impact factor: 3.396

Review 4.  Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.

Authors:  Madelon Pijls-Johannesma; Janneke P C Grutters; Frank Verhaegen; Philippe Lambin; Dirk De Ruysscher
Journal:  Oncologist       Date:  2010-01-12

5.  Assessment of the homogeneous efficacy of carbon ions in the spread-out Bragg peak for human lung cancer cell lines.

Authors:  Yasuo Takiguchi; Tadaaki Miyamoto; Keiichi Nagao; Takayuki Kuriyama
Journal:  Radiat Med       Date:  2007-07-27

6.  Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Authors:  Giulia Riva; Sara Imparato; Giovanni Savietto; Mattia Pecorilla; Alberto Iannalfi; Amelia Barcellini; Sara Ronchi; Maria Rosaria Fiore; Chiara Paganelli; Giulia Buizza; Mario Ciocca; Guido Baroni; Lorenzo Preda; Ester Orlandi
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

Review 7.  Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC.

Authors:  Harald Paganetti; Clemens Grassberger; Gregory C Sharp
Journal:  Semin Radiat Oncol       Date:  2021-04       Impact factor: 5.421

Review 8.  Advances in 4D treatment planning for scanned particle beam therapy - report of dedicated workshops.

Authors:  Christoph Bert; Christian Graeff; Marco Riboldi; Simeon Nill; Guido Baroni; Antje-Christin Knopf
Journal:  Technol Cancer Res Treat       Date:  2013-12-17

9.  Treatment Parameters Optimization to Compensate for Interfractional Anatomy Variability and Intrafractional Tumor Motion.

Authors:  Romain Brevet; Daniel Richter; Christian Graeff; Marco Durante; Christoph Bert
Journal:  Front Oncol       Date:  2015-12-24       Impact factor: 6.244

10.  Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells.

Authors:  Kazutoshi Murata; Shin-ei Noda; Takahiro Oike; Akihisa Takahashi; Yukari Yoshida; Yoshiyuki Suzuki; Tatsuya Ohno; Tomoo Funayama; Yasuhiko Kobayashi; Takeo Takahashi; Takashi Nakano
Journal:  J Radiat Res       Date:  2014-03-21       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.